Our mission is to improve
the lives of the millions that
suffer from food allergies
and gluten-related disorders
Food allergies and gluten-related disorders are on the rise,
with significant social, health, and economic impact
$25B
each year is spent on healthcare costs related to food allergies and disorders
1 in every 13 children in
the United States is affected by food allergies
new cases of celiac
disease have doubled every fifteen years
We are using cutting
edge technologies in immunology, computational biology, and protein engineering to develop a new approach
We are building a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, unlocking critical knowledge about the biological mechanisms that drive human food interactions.
On the basis of this map, we design proteins that do not trigger an immune response. These proteins are then applied to the food and therapeutics markets.
Founding Team
ANAT BINUR
CEO & Co-Founder
YANAY OFRAN
Chairman & Co-Founder
Our Advisors
ANN M. VENEMAN
Former US Secretary of Agriculture
.jpg)
BERNHARD VAN LENGERICH
Former Chief Science Officer & VP for Technology Strategy, General Mills
DR. WESLEY A. BURKS
Stuart Bondurant Distinguished Professor
Dean and CEO UNC School of Medicine and UNC Health
LYNDA SCHNEIDER
Director, Allergy Program
Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School
PROF. RAANAN SHAMIR
Chairman, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center
DR. STEFANO GUANDALINI
Founder and Medical Director of the Celiac Disease Center at the University of Chicago
DR. KARI NADEAU
Professor of Medicine
Stanford University
EDWIN KIM
Associate Professor, University of North Carolina; Director UNC Food Allergy Initiative
PEGGY OZIAS-AKINS
Director, Institute of Plant Breeding, Genetics and Genomics at the University of Georgia
Our Investors
